With three weeks remaining before the August recess, time is running short for the Senate to continue to meet regarding the SBIR bill. (NOTE: the House passed a SBIR reauthorization bill in April). Yesterday the Wall Street Journal ran a piece outlining the debate on who should receive these SBIR grants: Should a small business [...]
Filed under: Congress, In the News, SBIR, venture capital | Tagged: House, SBIR, Senate, VC, venture capital, Wall Street Journal | Leave a Comment »
Yesterday, the House voted overwhelmingly (368-43), to reauthorize the Small Business Innovation Research (SBIR) program. This bill will allow more biotechnology companies to compete for research funding.
This act will increase access to early-stage funding for treatments and cures for debilitating diseases. Congress has recognized the capital-intensive needs of emerging biotechnology companies, whose development of a [...]
Filed under: BIO, Congress, SBIR, patient groups, venture capital | Tagged: Committee, House, SBIR, Science, treatments | Leave a Comment »
